Stockscreener 앱 받기
6.73
4.67%
0.30
전일 마감가:
$6.43
열려 있는:
$6.41
하루 거래량:
74,154
Relative Volume:
0.57
시가총액:
$336.26M
수익:
$15.33M
순이익/손실:
$-40.19M
주가수익비율:
-3.8409
EPS:
-1.7522
순현금흐름:
-
1주 성능:
+4.02%
1개월 성능:
+43.19%
6개월 성능:
+30.43%
1년 성능:
+63.35%
1일 변동 폭
$6.41
$6.87
1주일 범위
$6.06
$7.3195
52주 변동 폭
$3.42
$7.3195
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
6.73 | 321.27M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Is TriSalus Life Sciences Inc. Equity Warrant stock vulnerable to regulatory risksJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
How TriSalus Life Sciences Inc. stock valuations compare to rivalsWeekly Risk Summary & AI Enhanced Trading Signals - Newser
TriSalus Life Sciences (Nasdaq: TLSI) plans Dec. 15 KOL event on TriNav PED-TAE - Stock Titan
How TriSalus Life Sciences Inc. stock reacts to job market dataPortfolio Value Report & Intraday High Probability Setup Alerts - Newser
Market Overview: Is Rush Enterprises Inc stock ready for breakoutJuly 2025 Trends & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will TriSalus Life Sciences Inc. Equity Warrant stock gain from lower inflationTrade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for growth ETFsJuly 2025 Short Interest & Technical Entry and Exit Tips - Newser
Bond Watch: What valuation multiples suggest for TriSalus Life Sciences Inc. stockMarket Performance Recap & High Accuracy Trade Alerts - BỘ NỘI VỤ
TriSalus Life Sciences (NASDAQ:TLSI) Upgraded by Wall Street Zen to Hold Rating - Defense World
What drives TriSalus Life Sciences Inc Equity Warrant stock priceLarge Cap Stability Picks & Options Trading Analysis Tools - earlytimes.in
This trade activity should not be overlooked: TriSalus Life Sciences Inc (TLSI) - Setenews
TriSalus Life Sciences (NASDAQ:TLSIW) Trading Up 2.5% – Here’s Why - Defense World
TriSalus Life Sciences Hits New 52-Week High at $5.95 - Markets Mojo
TLSI Surges As Trinav XP Launch And Q4 PERIO Results Put Investors On Alert - RTTNews
TriSalus (TLSI) Q3 2025 Earnings Call Transcript - AOL.com
Why TriSalus Life Sciences Inc. Equity Warrant stock appeals to analystsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Why hedge funds are buying TriSalus Life Sciences Inc. Equity Warrant stockGap Up & Safe Swing Trade Setups - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Research Analysts Offer Predictions for TLSI FY2026 Earnings - Defense World
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Index Update & Weekly Breakout Stock Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Is TriSalus Life Sciences Inc. stock a dividend growth opportunity2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How strong is TriSalus Life Sciences Inc. Equity Warrant stock revenue growthWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingJuly 2025 Retail & Verified Short-Term Plans - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantVolume Spike & Daily Market Momentum Tracking - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Levels & Low Risk Entry Point Guides - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity WarrantOil Prices & Capital Efficient Trading Techniques - newser.com
TriSalus Life Sciences Launches TriNav®? XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery?? - marketscreener.com
What’s next for TriSalus Life Sciences Inc. stock priceBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Trisalus Life Sciences launches Trinav® XP infusion system to expand options for pressure-enabled drug delivery - MarketScreener
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Eagle-Tribune
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.89%
4.92%
자본화:
|
볼륨(24시간):